A tRNA-derived RNA fragment elevated in acute myeloid leukemia promotes cell growth and survival by suppressing AGGF1 and is ...

Reaching the Pre-Specified 80th Event Triggers the Final Analysis of the Pivotal Phase 3 Trial -- Company to Report Topline Primary Endpoint ...

A large EBMT registry analysis of 3385 adults with AML in remission and measurable residual disease found that haploidentical ...

The activity of six different genes can help determine survival in patients with acute myeloid leukemia (AML), according to a ...

Key TakeawaysSellas shares fell 18% today after the company said its Phase 3 REGAL trial in acute myeloid leukemia reached the 80th death, which triggers the trial’s final analysis. The drop looks ...

Retail bulls discussed buying the dip and a potential buyout, while others also challenged survival estimates.

The exact cause of acute myeloid leukemia (AML) is unclear, but risk factors can include older age, radiation exposure, smoking, certain genetic conditions, and more. Acute myeloid leukemia (AML) is a ...

Medications for AML include chemotherapy and newer targeted therapies. With several options available, the right medication for you will depend on the specific characteristics of your cancer. Acute ...

The collective activity of all six genes, which the researchers called the PHFScore, divided patients into groups with ...

Researchers have led a global study that identified molecular predictors of survival among Black patients with acute myeloid leukemia (AML). The study suggests a need to modify current AML risk layers ...